ALNOV:EPA
Novacyt SA
€0.41
0.00%
(0.00) 1D
Nov 6, 5:35:21 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
€0.41
High
€0.41
Low
€0.40
Mkt. cap
27.19M
Avg. vol.
187.71K
Volume
119.78K
52-wk high
€1.04
52-wk low
€0.29
EPS
-€0.38
Shares outstanding
72.59M
No. of employees
228
Open
€0.41
High
€0.41
Low
€0.40
Mkt. cap
27.19M
Avg. vol.
187.71K
Volume
119.78K
52-wk high
€1.04
52-wk low
€0.29
EPS
-€0.38
Shares outstanding
72.59M
No. of employees
228
News stories
From web sources and news partners
marketscreener.com
·
47 minutes ago
Energy Flat as Traders Await Middle East Policy Plans - Energy Roundup
Nacionale
·
1 hour ago
Was Thursday's stock market drop the biggest ever? In points, yes. In percent, not even close
TradingView
·
1 hour ago
Nasdaq rebounds after tech selloff but sheds 3% for the week
www.tmgm.com
·
1 hour ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
FoundedJul 3, 2006
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitenovacyt.com